DermTech Profit Margin

The latest profit margin for DMTK is -5.72% as of March 2024. That compares with -8.2% in the prior-year period — up 30.2% year over year. That is below the Healthcare sector average of 15.58%. Investors often review this figure alongside DermTech's historical trend and sector peers before judging valuation or financial health.

Over the past year, DMTK's profit margin moved from -8.2% to -5.72% — a 30.2% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in DermTech's valuation or profitability profile.

Against Healthcare companies, DMTK currently prints -5.72% for profit margin, while the sector average sits near 15.58%. That is roughly 3771.6% below the sector mean. Large gaps often invite a closer look at DermTech's growth, margins, and balance sheet.

Profit Margin shows how effectively DermTech converts resources into returns. At -5.72%, DMTK may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -8.2% in the prior-year period — up 30.2% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting DMTK's profit margin (-5.72%), review year-over-year change from -8.2%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.